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Abstract  
Background: The relation between BMI and mortality is U-shaped in the elderly but may be 
modified by mid-life BMI and change in weight. 
Objective: To elucidate mortality prediction by BMI trajectory in older men. 
Subjects: The Oslo cohort of men born in 1923-32 were screened for BMI and cardiovascular 
risk in 1972-3. Survivors were rescreened at ages 68-77 years and all-cause mortality was 
followed from 2000 to 2011.  
Methods: We calculated Cox regression proportional hazards for 11-year mortality rates in 
relation to BMI change among 5,240 men with no reported disease in 1972-3 and complete 
data. Models were adjusted for demographics, medications and disease. Men with BMI <25 
kg/m2 in midlife (1972-73) and in 2000 were the reference group. 
Results: Men whose BMI changed from <25 kg/m2 in midlife to 25-29.9 kg/m2 in 2000 
carried the lowest mortality risk (hazard ratio [HR] 0.84; 95% CI 0.75-0.94). Men with BMI 
≥30 kg/m2 in midlife were at highest risk (HR 1.79; 95% CI 1.12-2.88 if reclassified to 25-
29.9 kg/m2 in 2000 and HR 1.39; 95% CI 1.05-1.85 if BMI remained ≥30 kg/m2 in 2000). 
Men with BMI 25-29.9 kg/m2 in midlife that reclassified to <25 kg/m2 in 2000 had increased 
risk. Findings were similar when percentage change in BMI was the outcome. 
Conclusion: Survival in older men with normal weight at midlife was associated with BMI 
gain after midlife while midlife obesity increased risk regardless of subsequent change. 
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The World Health Organization defined BMI-based categories of underweight, normal weight 
and obesity in 1997 largely based on studies examining morbidity risk in young and middle-
aged adults [1]. The category of BMI of 20 to 24.9 kg/m2 has the lowest all-cause mortality in 
prospective studies of white adults who never smoked and did not have diagnosed major 
diseases [2]. A meta-analysis using a broader inclusion range, but with exclusion of the first 5 
years of follow-up found that the optimum BMI may lie between 22.5-25 kg/m2 [3]. Recently, 
a meta-analysis of more than 2.88 million individuals and more than 270,000 deaths found 
that overweight was associated with lower all-cause mortality compared to normal weight [4].  
The ”obesity paradox” conveys the notion that in some populations overweight or obesity 
may protect against premature mortality. Particularly among the elderly, the shape of the 
association between BMI and mortality remains controversial. In meta-analyses, a BMI in the 
overweight range among the elderly was not associated with increased mortality [5], and 
together with subsequent findings has led to calls to amend BMI risk categories in older 
persons [5-7]. 
An important consideration in the obesity-mortality relationship is the question of 
weight stability. Use of a single measure of BMI raises several methodological concerns 
particularly in the elderly. Underweight is likely to indicate disease or frailty which contribute 
to mortality and weight loss may be the underlying culprit. Weight in old age may not reflect 
earlier weight; both earlier and later weights have been shown to independently affect risk [8]. 
In line with this, a dynamic measure of weight or BMI seems to be more predictive of 
mortality among older adults than a static one [9].  Weight loss associates with the worst 
prognosis even in people who were overweight earlier in life [10, 11], while weight gain in 
old age appears not to increase risk [12]. Stable overweight was shown to increase risk in 
Californians who never smoked and belonged to a demonimination encouraging a healthy 
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lifestyle [13] in contrast to findings in a general, more representative US population [9].  The 
degree of weight change may also be of importance [9] with large losses or gains shown to 
increase cardiovascular and all-cause mortality [14]. Clinically, losses of ∼5% are thought to 
be sustainable and lead to reductions in cardiovascular risk factors [15]. 
A further consideration is that studies of the BMI-mortality relationship conducted 
before the mid-1990s do not reflect changes in the enviroment that may affect the 
relationship. Public health efforts to stem the obesity epidemic may potentially flatten the risk 
curve (due to protective lifestyle changes). Medical risk factors like dyslipidemia and 
hypertension are increasingly identified and treated. Treatment of these risk factors in obese 
individuals may likewise ameliorate risk of premature mortality.    
The Oslo cohort was established in 1972-3 when 40–49 year old men residing in Oslo 
took part in a cardiovascular risk and BMI screening program [16]. Unfortunately, women 
were not invited to this program. The men were reinvited in 2000 to an expanded screening 
with additional data cellection and remeasurement of BMI [17]. At this screening, 28 years 
after the initial one, men were aged 68-77 years. We followed all cause mortality in this 
cohort from 2000 to 2011. Our objective was to explore the associations between BMI 
category in midlife, BMI category at older age (68-77 years) and weight change and 11-year 
all-cause mortality. We controlled for variables that may confound the association between 
weight change and mortality including illness, smoking, and medication use.   
Material and methods 
The Oslo Study has been described in detail elsewhere [16]. Briefly, 16,203 men born 
in 1923-32 participated in a screening examination in 1972-3 with an attendance proportion of 
~65%. Conventional cardiovascular risk factors including nonfasting total cholesterol, blood 
pressure and cigarette smoking were assessed. In addition, body height and weight (but not 
 5 
waist circumference) were measured and BMI calculated. In the year 2000 the surviving men 
(N=12,764) in this cohort were invited to a new screening examination and 6,016 (47.1%) 
took part [17]. In this rescreening, the same variables and methods were applied as in 1972-3; 
in addition, questions about educational length, occurrence of chronic diseases from 1972-3 to 
present and use of drugs were posed, including use of antihypertensive and lipid lowering 
drugs. Waist circumference was measured over the umbilicus. Men with a history of previous 
cardiovascular diseases, established hypertension or diabetes in 1972-3 were excluded in the 
current analyses due to the confounding effects of disease on BMI and mortality. Excluded 
men had higher major risk factor levels than men without the defined health problems as 
described previously [16]. This left 5,738 men. Of these 5,239 with complete data were 
included. All cause mortality was the end point for the analyses from screening in 2000 to 
December 31st 2011. The number of deaths was 2,145 among 5,239 men at risk. 
This study was approved by a Regional Ethics Committee for scientific research in 
Norway, the Norwegian Data Inspectorate, and the Ministry of Health and the study complies 
with the Declaration of Helsinki. 
Statistics 
Descriptive statistics were used to compare risk factors in men with complete versus 
incomplete data and in men who died compared with survivors using t-tests or Chi-square as 
appropriate. In Cox regression models, time to death was the dependent variable. BMI in 
1972-3 and in 2000 were the main exposure variables and were categorized according to 
WHO as normal weight (BMI 18.5-24.9 kg/m2), overweight (BMI 25-29.9 kg/m2) or obese 
(BMI 30 ≥kg/m2). Those who were underweight (BMI <18.5 kg/m2) at either screening were 
excluded in the regression models (n=44). We also categorized BMI change according to 
percentage change between 1972-3 and 2000 with cut-offs of ±5% as the reference, and >5% 
increase or >5% decrease as comparators. Age, educational length, smoking, use of 
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antihypertensive or lipid lowering drugs, diabetes, previous myocardial infarction or cerebral 
stroke were adjustment variables in all analyses. A time variant Cox model tested the 
assumption of proportional hazards by adding a multiplicative interaction term between time 
and BMI in the model, with or without adjustments. None was found to be significant. Hazard 
ratios (HR) with 95 % confidence limits were calculated. Analyses were performed in SPSS 
18.0. 
 
Results 
At the rescreening in 2000, the median age of the subjects was 73 years (range 68-77 years). 
The 499 men who were excluded from the analyses because of missing data were slightly 
older (mean [SD] 73.0 [2.9] years versus 72.5 [2.8]), had a shorter education (11.4 [3.5] years 
versus 12.0 [3.8]) years, slightly higher BMI (26.8 [3.5] kg/m2 versus 26.3 [3.3] and included 
a higher proportion of smokers (20.7% versus 17.3%), users of antihypertensive (60.5% 
versus 32.1%) and lipid-lowering medication (32.6% versus 19.3%) and individuals with a 
history of diabetes (12.2% versus 6.2%), myocardial infarction (16.6% versus 11.5%) or 
cerebrovascular disease (11.6% versus 7.1%).  
Compared to survivors (n=3,094), men who died (n=2,145) were older with a mean 
age of 73.5 years (SD 2.8) than men who survived who had a mean age of 72.2 (SD 2.8). Men 
who died reported a shorter education of 11.7 years (SD 3.8) compared to men who survived 
who reported 12.3 (SD 3.8) years of education. Among men who died, 23.5% were smokers 
versus 13.1% of survivors, 37.6% used antihypertensive medication, versus 28.2% of 
survivors, 20.3% used lipid-lowering medication versus 18.6% of survivors, 8.6% had a 
diagnosis of diabetes versus 4.5% of survivors, 15.9% had experienced a myocardial 
infarction versus 8.5% of survivors and 10.3% had cerebrovascular disease versus 4.8% of 
survivors. 
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Association between BMI and mortality 
All-cause mortality was lowest in men with the mid-range of BMIs from 22.0-27.4 
kg/m2 in univariate analyses (Table 1). After adjustment for age, education, smoking, use of 
lipid-lowering or antihypertensive drugs, diabetes or cardiovascular disease only the extremes 
of the BMI distribution were associated with increased mortality (Table 1).  
 
Mortality relative to midlife BMI and change in BMI 
Of the total, 31.5% of men classified to the normal BMI category in 1972-3 and 2000, 
30.2% moved from the normal to the overweight BMI category between 1972-3 and 2000, 
while only 1.8% moved from the normal to the obese category (Table 2). Among all men 
again, 3.1% moved from the overweight to the normal weight category, 22.3% stayed in the 
overweight category, while 8.8% moved from the overweight to the obese category. Finally, 
only two men in the obese category moved to the normal weight category, 0.5% moved from 
the obese to the overweight category, and 1.7% stayed in the obese category. As shown in 
table 2, in Cox regression models, men in the normal BMI category in 1972-3 who increased 
their weight to the overweight category had lower mortality compared to those in the normal 
BMI category in both 1972-3 and 2000 (reference group). Likewise BMI increase of >5% in 
this group was associated with lower mortality compared to the reference group with ±5% 
change (Table 3). In obese men, reclassification to the overweight category or remaining in 
the obese category were associated with increased mortality (Table 3) as was weight loss of 
>5% or weight stability with ±5% change in BMI (Table 3). Finally weight loss in overweight 
men in 1972-3 was associated with increased mortality (Tables 2 & 3). 
 
Discussion 
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Our 11-year follow-up study suggests that all-cause mortality in older men in their 7th 
to 8th decades is lowest in those with normal BMI in middle age, who reclassified to the 
overweight category in the course of aging. This group constituted just under one-third of the 
total population. Men who were obese in midlife had an increased risk of mortality regardless 
of weight stability or weight loss, but constituted a very small part of this cohort born in 1972-
3 (about 2%). Men in the overweight category in midlife only had an increase in mortality if 
they lost weight, reclassifying to the normal weight category. Results were similar when 
examined as percentage BMI change rather than BMI classification. 
Our findings are in line with other studies using similar designs [6-12], underscoring 
the notion that in aging men, current BMI categories may not describe risk precisely as in 
younger individuals. In a meta-analysis of 65 years or older men and women mostly residing 
in North America and Europe, the risk estimate for BMI within the overweight range was 1.0 
and only a 10% increase in risk was estimated for the obese range [5]. Likewise among older 
individuals residing in Sweden, persons aged 70 to 95 in the overweight group had the lowest 
mortality of the cohort [6]. Among Framingham study participants, mortality risk was 
increased in obese persons who were obese at midlife, but not those who became obese in 
older age [8]. Strandberg et al studied a Finnish cohort of men parallel to the present one in 
time with baseline measurements in 1974 and follow-up in 2000 [10]. Among these 1,114 
men, only those who reclassified from overweight to normal BMI experienced an increase in 
mortality. Zheng et al using attributable risk analyses found that trajectories of increasing 
obesity past 51 years of age reduced life expectancy, but the overweight stable trajectory had 
the lowest mortality risk followed by people in the overweight to obesity and normal weight 
upward classes [9]. 
The effect of excess weight may be obscured if body weight is measured after disease 
onset.  Preexisting disease causing weight loss is an unavoidable confounder of the BMI-
 9 
mortality relation, and is observed even when death in the first years of follow-up are 
removed [3], and in non-smoker populations [2, 18]. Another limitation of observational 
studies is the possibility that in medium to long-term studies those individuals most 
susceptible to the effects of obesity will have succumbed earlier. Survivors may have a 
healthy form of obesity, providing advantages in aging [19]. However, this assumes that 
obesity was the cause of their underlying disease, which may not be the case [20].  These 
problems cannot be addressed with most observational data. We did not ask about 
intentionality of weight loss – in meta-analysis, intentional weight loss had a neutral effect on 
all-cause mortality, in contrast to ill-defined or non-intentional loss [21]. 
More difficult to explain is the observation that weight gain (but not in the obese) 
appears to lower mortality. Some evidence supports the notion that overweight and obesity 
may be less risky in recent compared to older studies. Obese people may come sooner to 
medical attention and be treated. Janssen & Mark in their 2009 meta-analysis found lower risk 
estimates (significantly <1.00) for overweight and obese categories in studies with baselines 
measured after 1990 compared to studies between 1957-1990 [5].  Increased lean tissue and 
fat mass may protect against disease associated with aging. In the elderly fat mass increases 
due to an age-related loss of fat free mass and BMI may not reflect risk as accurately as fat 
mass, or abdominal adiposity. While meta-analysis supported this notion [22], a large study of 
subjects over 65 years of age found no association of waist circumference and mortality after 
adjustment for BMI [23]. We found no relation between waist circumference measured in 
2000 and mortality in this cohort of men (data not shown). Findings from observational 
studies are buttressed by recent clinical data. The Look AHEAD trial found that lifestyle 
interventions leading to weight loss did not reduce cardiovascular events in middle-aged and 
elderly adults with diabetes [24].  
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 We used the WHO-designated categorization of BMI [1] that is widely used as the 
standard for defining normal weight, overweight and obesity. However, the category of 18.5-
24.9 kg/m2  that defines normal weight may encompass individuals with clinical cachexia, and 
a cut-off of BMI <20.0 kg/m2 which helps define cachexia in chronic disease may be more 
relevant [25]. 
Limitations 
 We studied solely white men, and looked only at total mortality, not cause-specific 
mortality. The shape of the BMI-mortality curve differs by the cause of mortality [14]. Our 
cohort included only a small number of individuals that were obese at baseline and does not 
represent current cohorts who may be obese from an earlier age. Despite the low number we 
found that obesity in midlife significantly increased risk to old age. We lacked childhood and 
early adult measures of BMI, thus, we did not capture the lifelong trajectory of BMI. 
Mortality risks appear higher in persons who attained a high BMI at a younger age than those 
who gain weight later in life [26]. 
 Subjects with missing data were unhealthier than the rest of the cohort; the effect of 
such selection is difficult to estimate. Missing data may lead to diluted associations because of 
restriction of variation in risk factors. We did not perform a multiple imputation analysis as 
distributions of missing factors cannot be assumed to be the same as in those without missing 
data. 
Conclusions 
 Survival in older men with normal BMI at midlife was associated with BMI gain after 
midlife.  The counterpart of this finding was that midlife obesity reduced longevity regardless 
of subsequent change in weight. These findings underscore the importance of studying the life 
trajectory of the BMI-mortality relationship.
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Table 1 Relationship between BMI measured in the year 2000 in 5,239 men and mortality 
between 2000 and 2011 (number of deaths, 2,145). Hazard ratios with 95% confidence 
intervals are shown. 
___________________________________________________________________________ 
 
BMI category, kg/m2 Univariate hazard ratio (95% CI) Adjusted* hazard ratio (95% CI) 
   _______________________________________________________ 
 
18.5-21.9  1.36 (1.16-1.59)   1.31 (1.12-1.54) 
22.0-24.9  Referent    Referent 
25.0-27.4  0.93 (0.83-1.04)   0.91 (0.78-1.00) 
27.5-29.9  0.90 (0.79-1.02)   0.86 (0.76-0.98) 
30.0-34.9  1.27 (1.10-1.47)   1.15 (0.99-1.33) 
≥35   1.38 (0.95-2.01)    1.26 (0.86-1.83) 
P (RD)**   <0.001     <0.001 
___________________________________________________________________________ 
 
*Adjustment factors: age, years of education, smoking (never, previous, current),  
use of antihypertensive medication, use of cholesterol lowering 
medication, diabetes, myocardial infarction, and cerebrovascular disease. 
 
**RD= global differences in relative risk between BMI groups. 
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Table 2. Number of deaths/men at risk and hazard ratios for mortality between 2000 and 2011 
according to BMI category in 1972-3 and BMI category in 2000. Data are adjusted for age, 
years of education, smoking (never, previous, current), use of antihypertensive medication, 
use of cholesterol lowering medication, diabetes, myocardial infarction, and cerebrovascular 
disease. Men with BMI <18.5 kg/m2 in year 2000 are excluded due to underweight. 
          
BMI in 1972-3 BMI in 2000 
18.5-25.0 kg/m2 
BMI in 2000 
25-29.9 kg/m2 
BMI in 2000 
≥30 kg/m2 
Normal 
18.5-25 kg/m2 
670/1,636 
1.0 (Reference) 
 
546/1,571 
0.84 (0.75-0.94) 
 
38/93 
1.01 (0.73-1.40) 
 
Overweight 
25-29.9 kg/m2 
93/162 
1.43 (1.15-1.78) 
 
484/1,160 
0.93 (0.82-1.05) 
 
214/455 
1.12 (0.96-1.31) 
 
Obese 
≥30 kg/m2 
1/2 
2.79 (0.39-19.9) 
 
18/26 
1.79 (1.12-2.88) 
 
53/90 
1.39 (1.05-1.85) 
 
 
 
 16 
Table 3. Number of deaths/men at risk and hazard ratios for mortality between 2000 and 2011 
according to BMI category in 1972-3 and % change in BMI between 1972-3 and 2000. Data 
are adjusted for age, years of education, smoking (never, previous, current), use of 
antihypertensive medication, use of cholesterol lowering medication, diabetes, myocardial 
infarction, and cerebrovascular disease. Men with BMI <18.5 kg/m2 are excluded due to 
underweight. 
 
BMI in 1972-3 >5% decrease in BMI 
between 1972-3 and 
2000 
± 5% change in BMI 
between 1972-3 and 
2000 
>5% increase in BMI 
between 1972-3 and 
2000 
Normal 
18.5-25 kg/m2 
106/159 
2.01 (1.62-2.49) 
 
384/950 
1.0 (Reference) 
 
764/2,191 
0.87 (0.77-0.99) 
 
Overweight 
25-29.9 kg/m2 
99/165 
1.46 (1.17-1.83) 
 
262/603 
0.99 (0.85-1.17) 
 
430/1,009 
1.02 (0.89-1.18) 
Obese 
≥30 kg/m2 
20/28 
1.68 (1.06-2.65) 
 
25/40 
1.68 (1.12-2.54) 
 
 
27/50 
1.35 (0.91-2.00) 
 
 
 
 
  
